ACM
MRNA icon

Aquatic Capital Management’s Moderna MRNA Stock Holding History

Aquatic Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-549,671
Closed -$16.2M – 1657
2025
Q4 		$16.2M Buy
549,671
+508,618
+1,239% +$13.8M 0.46% 49
2025
Q3 		$1.06M Buy
+41,053
New +$1.15M 0.02% 657
2025
Q1 		– Sell
-181,982
Closed -$7.57M – 1498
2024
Q4 		$7.57M Sell
181,982
-97,418
-35% -$4.66M 0.2% 127
2024
Q3 		$18.7M Buy
279,400
+202,300
+262% +$18.6M 0.49% 52
2024
Q2 		$9.16M Buy
+77,100
New +$9.76M 0.34% 75
2022
Q4 		– Sell
-10,600
Closed -$1.25M – 1650
2022
Q3 		$1.25M Buy
+10,600
New +$1.61M 0.12% 222
2022
Q2 		– Sell
-100
Closed -$17K – 1435
2022
Q1 		$17K Buy
+100
New +$16.8K 0.03% 536

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aquatic Capital Management's MRNA Position: Q1 2026 in Review

Aquatic Capital Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 549,671 shares — an estimated $16.2M sold.

Aquatic Capital Management first reported a position in MRNA in Q1 2022 and held it in 7 quarters. The position peaked at $18.7M in Q3 2024. 725 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Aquatic Capital Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 549,671 Moderna shares in Q1 2026, an estimated $16.2M.
  • Aquatic Capital Management first reported a position in Moderna in Q1 2022 and held it in 7 quarters.
  • Aquatic Capital Management's Moderna position peaked at $18.7M in Q3 2024.
  • 725 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.